DAIKEN MEDICAL
DAIKEN MEDICAL CO.,LTD
Company highlights
The company has paid a dividend for 11 consecutive years.
Key figures
Period Apr 2025 to Mar 2026Parent onlyJapanese GAAP
Company profile
Tables scroll sideways
Disclosed data
Business activities and revenue composition
Revenue and profit by business segment
Disclosed segments (business divisions used in reporting): one
Revenue and profit
DAIKEN MEDICAL
Period Apr 2025 to Mar 2026Source Annual securities reports
Amounts by account
| Group | Account | Amount | Consolidated / Non-consolidated |
|---|---|---|---|
| Selling, general and administrative expenses | Employees' salaries and allowances | ¥0.7 billion | Parent only |
| Research and development expenses | ¥0.4 billion | Parent only | |
| Freight out | ¥0.3 billion | Parent only | |
| Depreciation | ¥45.57 million | Parent only | |
| Provision of allowance for doubtful accounts | ¥0.04 million | Parent only | |
| Profit by stage | Gross profit (loss) | ¥4.0 billion | Parent only |
| Operating income | ¥1.3 billion | Parent only | |
| Ordinary income | ¥1.3 billion | Parent only |
DAIKEN MEDICAL
Selling, general and administrative expenses
Period Apr 2025 to Mar 2026Source Annual securities reports
- Employees' salaries and allowances ¥0.7 billion
- Research and development expenses ¥0.4 billion
- Freight out ¥0.3 billion
- Depreciation ¥0.0 billion
- Provision of allowance for doubtful accounts ¥0.0 billion
- Other (not itemized) ¥1.3 billion
Performance, financial position and capital allocation
Long-term changes in performance
DAIKEN MEDICAL
Long-term revenue, profit and asset trends
Period 2013 to 2026Source Annual securities reportsDisclosed
DAIKEN MEDICAL
Recent performance trends
Source Annual securities reports
Year-on-year comparison
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales | ¥8.5B | ¥9.1B | ¥9.8B | ¥10.0B | ¥10.3B |
| Year on year (%) | +8.6% | +7.0% | +6.7% | +2.1% | +3.4% |
| Ordinary income (loss) | ¥1.2B | ¥1.1B | ¥1.4B | ¥1.5B | ¥1.3B |
| Change from prior year | +20.4% | -8.6% | +37.6% | +4.1% | -15.6% |
| Ordinary income (loss) as a share of Net sales | 13.5% | 11.5% | 14.9% | 15.2% | 12.4% |
| Change (percentage points) | +1.3 points | -2.0 points | +3.3 points◆ | +0.3 points | -2.8 points◆ |
Fiscal periods marked for changes
Earlier fiscal periods (2)
- 2018Ordinary income (loss) as a share of revenue -2.9 points
- 2019Ordinary income (loss) as a share of revenue -2.7 points
- 2021Ordinary income (loss) as a share of revenue -2.0 points
- 2024Ordinary income (loss) as a share of revenue +3.3 points
- 2026Ordinary income (loss) as a share of revenue -2.8 points
DAIKEN MEDICAL
Earnings and net assets per share over time
Unit yenSource Annual securities reports
DAIKEN MEDICAL
Return on equity over time
Unit %Source Annual securities reports
Parent only indicators (18 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | ¥8.5 billion | ¥9.1 billion | ¥9.8 billion | ¥10.0 billion | ¥10.3 billion |
| Ordinary income (loss) | ¥1.2 billion | ¥1.1 billion | ¥1.4 billion | ¥1.5 billion | ¥1.3 billion |
| Net income (loss) | ¥0.8 billion | ¥0.7 billion | ¥1.0 billion | ¥1.1 billion | ¥0.9 billion |
| Capital stock | ¥0.5 billion | ¥0.5 billion | ¥0.5 billion | ¥0.5 billion | ¥0.5 billion |
| Total number of issued shares (common stock) | 31,840,000 shares | 31,840,000 shares | 31,840,000 shares | 31,840,000 shares | 31,840,000 shares |
| Net assets | ¥6.4 billion | ¥6.6 billion | ¥7.0 billion | ¥7.5 billion | ¥7.8 billion |
| Total assets | ¥10.9 billion | ¥11.0 billion | ¥11.0 billion | ¥11.2 billion | ¥11.4 billion |
| Net assets per share | 224.13 yen | 228.91 yen | 243.32 yen | 260.53 yen | 269.65 yen |
| Dividend per share | 20 yen | 20 yen | 21 yen | 23 yen | 20 yen |
| Interim dividend per share | 9 yen | 9 yen | 9 yen | 9 yen | 9 yen |
| Basic earnings (loss) per share | 28.93 yen | 24.79 yen | 34.41 yen | 38.21 yen | 32.12 yen |
| Equity-to-asset ratio | 59.0% | 59.7% | 63.5% | 66.9% | 68.2% |
| Return on equity | 13.2% | 10.9% | 14.6% | 15.2% | 12.1% |
| Payout ratio | 69.1% | 80.7% | 61.0% | 60.2% | 62.3% |
| Net cash provided by (used in) operating activities | ¥1.1 billion | ¥1.0 billion | ¥1.6 billion | ¥1.1 billion | ¥0.6 billion |
| Net cash provided by (used in) investing activities | ¥-0.2 billion | ¥-0.2 billion | ¥-0.2 billion | ¥-0.2 billion | ¥-0.3 billion |
| Net cash provided by (used in) financing activities | ¥-0.6 billion | ¥-0.8 billion | ¥-1.2 billion | ¥-0.7 billion | ¥-0.5 billion |
| Cash and cash equivalents | ¥2.5 billion | ¥2.5 billion | ¥2.7 billion | ¥3.0 billion | ¥2.8 billion |
Dividend history
| Fiscal year | Annual dividend per share | Of which interim | Payout ratio (as reported, parent only) | Flag |
|---|---|---|---|---|
| FY ending 3/2026 | ¥20 | ¥9 | 62.3% | |
| FY ending 3/2025 | ¥23 | ¥9 | 60.2% | |
| FY ending 3/2024 | ¥21 | ¥9 | 61.0% | |
| FY ending 3/2023 | ¥20 | ¥9 | 80.7% | |
| FY ending 3/2022 | ¥20 | ¥9 | 69.1% | |
| FY ending 3/2021 | ¥20 | ¥9 | 85.1% | |
| FY ending 3/2020 | ¥20 | ¥9 | 66.8% | |
| FY ending 3/2019 | ¥20 | ¥10 | 68.8% | |
| FY ending 3/2018 | ¥25 | ¥9 | 74.0% | |
| FY ending 3/2017 | ¥25 | ¥7 | 60.2% | |
| FY ending 3/2016 | ¥16 | ¥7 | 41.6% | |
| FY ending 3/2015 | ¥21 | ¥12 | 41.3% | Stock split or share consolidation noted |
| FY ending 3/2014 | ¥24 | ¥11.75 | 41.1% | Stock split or share consolidation noted |
| FY ending 3/2013 | ¥43 | Could not be retrieved | 40.5% |
DAIKEN MEDICAL
Dividends per share over time
Unit yenSource Annual securities reports
Shareholder composition
Share ownership by holder category
DAIKEN MEDICAL
Unit %Source Annual securities reports
- Financial institutions0.53%
- Securities firms0.95%
- Other corporations3.82%
- Foreign holders (institutions)2.30%
- Foreign holders (individuals)0.07%
- Individuals and others92.33%
Major shareholders
| Rank | Shareholder | Shareholding ratio | Shares held |
|---|---|---|---|
| 1 | 山田 圭一 | 19.01% | 5,462,000 |
| 2 | 山田 満 | 13.92% | 4,000,000 |
| 3 | 山田 雅之 | 10.89% | 3,129,000 |
| 4 | 公益財団法人山田満育英会 | 3.48% | 1,000,000 |
| 5 | 関家 圭三 | 3.31% | 950,000 |
| 6 | 大研医器従業員持株会 | 0.93% | 266,000 |
| 7 | 寺田 恭子 | 0.9% | 258,000 |
| 8 | 羽根 一徳 | 0.7% | 200,000 |
| 9 | 山田 すみれ | 0.7% | 200,000 |
| 10 | 磐下 裕司 | 0.62% | 179,000 |
Research and development expenses and capital expenditure
| Fiscal year | Research and development | Capital expenditure |
|---|---|---|
| FY ending 3/2026 | ¥0.4 billion | ¥0.2 billion |
| FY ending 3/2025 | ¥0.3 billion | Could not be retrieved |
| FY ending 3/2021 | ¥0.4 billion | ¥0.4 billion |
Revenue scale in the same industry
DAIKEN MEDICAL
Source Annual securities reports of each company
Precision Instruments: 54 companies · revenue · largest first・each company’s latest fiscal year・consolidated (parent-only where no consolidated figures)・Disclosed
- 1 TERUMOFY Mar 2026 ¥1.1T
- 2 OLYMPUSFY Mar 2026 ¥1.0T
- 3 NIKONFY Mar 2026 ¥677.2B
- … 36 companies
- 40 KitazatoFY Mar 2026 ¥10.9B
- 41 3-D MatrixFY Apr 2026 ¥10.9B
- 42 DAIKEN MEDICALThis companyFY Mar 2026 ¥10.3B
- 43 Nihon SeimitsuFY Mar 2026 ¥7.9B
- 44 SincereFY Dec 2025 ¥7.5B
- … 10 companies
Workforce information
Administrative filings and published information
Workplace information filings
| Item | Value |
|---|---|
| Employees | 284 |
| Annual paid leave taken |
63.5% |
| Childcare leave taken, men |
29% |
| Childcare leave taken, women |
100% |
| Share of managers who are women | 7.7% |
| Share of board members who are women | 14.2% |
Audit and disclosure information
| Item | Value |
|---|---|
| Audit firm | 有限責任あずさ監査法人 |
| Audit fees (this year, filing company) | ¥26.30 million |
| Non-audit fees (this year, total) | Not applicable |
| Going concern note | Cannot be determined |
| Accounting standard | Japanese GAAP |
Related books, articles and videos
Sources and methodology
Retrieved disclosed figures
Major management indicators (5 years) (18 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Dividend per share | 20 yen | Parent only |
| Net cash provided by (used in) operating activities | ¥0.6 billion | Parent only |
| Net sales | ¥10.3 billion | Parent only |
| Net income (loss) | ¥0.9 billion | Parent only |
| Net cash provided by (used in) investing activities | ¥-0.3 billion | Parent only |
| Cash and cash equivalents | ¥2.8 billion | Parent only |
| Total number of issued shares (common stock) | 31,840,000 shares | Parent only |
| Net assets | ¥7.8 billion | Parent only |
| Ordinary income (loss) | ¥1.3 billion | Parent only |
| Total assets | ¥11.4 billion | Parent only |
| Return on equity | 12.1% | Parent only |
| Equity-to-asset ratio | 68.2% | Parent only |
| Net cash provided by (used in) financing activities | ¥-0.5 billion | Parent only |
| Capital stock | ¥0.5 billion | Parent only |
| Payout ratio | 62.3% | Parent only |
| Interim dividend per share | 9 yen | Parent only |
| Basic earnings (loss) per share | 32.12 yen | Parent only |
| Net assets per share | 269.65 yen | Parent only |
Employees (10 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Wage gap between men and women (all employees) | 37.6% | Parent only |
| Average length of service (years) | 12 years | Parent only |
| Average length of service months | 8 months | Parent only |
| Average annual salary | ¥6.46 million | Parent only |
| Average age (years) | 42 years old | Parent only |
| Average age months | 11 months | Parent only |
| Number of employees | 185 people | Parent only |
| Number of employees | 185 people | Parent only |
| Wage gap between men and women (regular employees) | 58.7% | Parent only |
| Wage gap between men and women (non-regular employees) | 77.2% | Parent only |
Other disclosed items (5 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Rate of male employees taking childcare leave (all employees) | 28.6% | Parent only |
| Average number of temporary employees | 110 people | Parent only |
| Average number of temporary employees | 110 people | Parent only |
| Total return on the share price index | 202.2% | Parent only |
| Ratio of female employees in managerial positions | 7.7% | Parent only |
Shares (8 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Number of shares held | 15,645,000 shares | Consolidated |
| Total number of shares held treasury shares etc | 3,111,500 shares | Consolidated |
| Number of shares | 31,840,000 shares | Consolidated |
| Shareholding ratio treasury shares etc | 9.8% | Consolidated |
| Shareholding ratio | 54.5% | Consolidated |
| Number of shares held in own name treasury shares etc | 3,111,500 shares | Consolidated |
| Number of voting rights | 287,033 units | Consolidated |
| Total shareholder return | 90.6% | Parent only |
Research and development (2 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Research and development expenses | ¥0.4 billion | Consolidated |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | ¥0.4 billion | Parent only |
Property and facilities (1 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Capital expenditures | ¥0.2 billion | Consolidated |
Audit (1 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Fees for audit and attestation services - reporting company | ¥26.30 million | Consolidated |
Accounts unique to this company (2 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Change in average annual salary from the previous year | -1.0% | Parent only |
| Revenue | ¥8.21 million | Parent only |
Balance sheet (69 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Other | ¥1.69 million | Parent only |
| Other | ¥4.75 million | Parent only |
| Other | ¥57.05 million | Parent only |
| Software | ¥14.17 million | Parent only |
| Software in progress | ¥3.35 million | Parent only |
| Lease obligations | ¥14.12 million | Parent only |
| Lease obligations | ¥5.72 million | Parent only |
| Lease assets, net | ¥17.67 million | Parent only |
| Work in process | ¥88.88 million | Parent only |
| Membership | ¥13.10 million | Parent only |
| Investments in capital | ¥0.01 million | Parent only |
| General reserve | ¥0.7 billion | Parent only |
| Retained earnings | ¥8.7 billion | Parent only |
| Legal retained earnings | ¥23.75 million | Parent only |
| Prepaid expenses | ¥30.45 million | Parent only |
| Raw materials | ¥0.4 billion | Parent only |
| Notes receivable - trade | ¥7.56 million | Parent only |
| Non-current liabilities | ¥0.9 billion | Parent only |
| Non-current assets | ¥4.3 billion | Parent only |
| Land | ¥1.7 billion | Parent only |
| Accounts receivable - trade | ¥1.2 billion | Parent only |
| Tools, furniture and fixtures | ¥0.1 billion | Parent only |
| Guarantee deposits | ¥51.52 million | Parent only |
| Buildings, net | ¥1.7 billion | Parent only |
| Construction in progress | ¥0.3 billion | Parent only |
| Investments and other assets | ¥0.3 billion | Parent only |
| Subscription rights to shares | ¥30.97 million | Parent only |
| Property, plant and equipment | ¥4.0 billion | Parent only |
| Income taxes payable | ¥0.2 billion | Parent only |
| Accrued expenses | ¥76.60 million | Parent only |
| Accounts payable - other | ¥0.4 billion | Parent only |
| Shareholders' equity | ¥7.7 billion | Parent only |
| Structures, net | ¥0.61 million | Parent only |
| Machinery and equipment, net | ¥0.2 billion | Parent only |
| Current liabilities | ¥2.7 billion | Parent only |
| Current assets | ¥7.0 billion | Parent only |
| Accumulated depreciation | ¥-3.9 billion | Parent only |
| Intangible assets | ¥22.62 million | Parent only |
| Cash and cash equivalents | ¥2.8 billion | Parent only |
| Cash and deposits | ¥2.8 billion | Parent only |
| Life insurance funds | ¥8.80 million | Parent only |
| Short-term loans payable | ¥0.9 billion | Parent only |
| Claims provable in bankruptcy claims provable in rehabilitation and other | ¥0.04 million | Parent only |
| Net assets | ¥7.8 billion | Parent only |
| Net assets | ¥7.8 billion | Parent only |
| Total assets | ¥11.4 billion | Parent only |
| Deferred tax assets | ¥0.2 billion | Parent only |
| Retained earnings brought forward | ¥8.0 billion | Parent only |
| Treasury stock | ¥-1.8 billion | Parent only |
| Finished goods | ¥1.1 billion | Parent only |
| Electronically recorded obligations for facilities | ¥19.81 million | Parent only |
| Liabilities | ¥3.6 billion | Parent only |
| Liabilities and net assets | ¥11.4 billion | Parent only |
| Accounts payable - trade | ¥0.6 billion | Parent only |
| Allowance for doubtful accounts | ¥-24.69 million | Parent only |
| Allowance for doubtful accounts | ¥-0.10 million | Parent only |
| Capital surplus | ¥0.4 billion | Parent only |
| Legal capital surplus | ¥0.4 billion | Parent only |
| Capital stock | ¥0.5 billion | Parent only |
| Vehicles, net | ¥0.17 million | Parent only |
| Long-term loans payable | ¥0.8 billion | Parent only |
| Long-term prepaid expenses | ¥4.39 million | Parent only |
| Long-term accounts receivable-other | ¥13.15 million | Parent only |
| Long term guarantee deposited | ¥11.50 million | Parent only |
| Electronically recorded obligations - operating | ¥0.1 billion | Parent only |
| Electronically recorded monetary claims - operating | ¥1.3 billion | Parent only |
| Telephone subscription right | ¥5.10 million | Parent only |
| Deposits received | ¥12.32 million | Parent only |
| Current portion of long-term loans payable | ¥0.5 billion | Parent only |
Statement of income (45 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Other | ¥0.03 million | Parent only |
| Gain on sales of scrap | ¥0.48 million | Parent only |
| Transfer to other accounts | ¥44.61 million | Parent only |
| Dividends from surplus | ¥-0.7 billion | Parent only |
| Insurance fee income | ¥1.10 million | Parent only |
| Interest income | ¥1.86 million | Parent only |
| Commission fee | ¥1.11 million | Parent only |
| Guaranty money income | ¥1.03 million | Parent only |
| Total | ¥7.4 billion | Parent only |
| Operating income | ¥1.3 billion | Parent only |
| Non-operating income | ¥9.15 million | Parent only |
| Non-operating expenses | ¥12.36 million | Parent only |
| Net cash provided by (used in) operating activities | ¥0.6 billion | Parent only |
| Loss on retirement of non-current assets | ¥28.70 million | Parent only |
| Cost of sales | ¥6.3 billion | Parent only |
| Gross profit (loss) | ¥4.0 billion | Parent only |
| Net sales | ¥10.3 billion | Parent only |
| Cost of purchased goods | ¥0.2 billion | Parent only |
| Net income (loss) | ¥0.9 billion | Parent only |
| Net income (loss) | ¥0.9 billion | Parent only |
| Cost of products manufactured | ¥6.3 billion | Parent only |
| Employees' salaries and allowances | ¥0.7 billion | Parent only |
| Net cash provided by (used in) investing activities | ¥-0.3 billion | Parent only |
| Interest expenses | ¥12.34 million | Parent only |
| Gain on reversal of share acquisition rights | ¥0.40 million | Parent only |
| Gain on forfeiture of unclaimed dividends | ¥0.62 million | Parent only |
| Income taxes - current | ¥0.3 billion | Parent only |
| Income taxes | ¥0.3 billion | Parent only |
| Income taxes - deferred | ¥-22.20 million | Parent only |
| Depreciation | ¥45.57 million | Parent only |
| Foreign exchange gains | ¥2.36 million | Parent only |
| Extraordinary income | ¥0.40 million | Parent only |
| Extraordinary loss | ¥28.70 million | Parent only |
| Net increase (decrease) in cash and cash equivalents | ¥-0.2 billion | Parent only |
| Freight out | ¥0.3 billion | Parent only |
| Research and development expenses | ¥0.4 billion | Parent only |
| Income (loss) before income taxes | ¥1.2 billion | Parent only |
| Income (loss) before income taxes | ¥1.2 billion | Parent only |
| Ordinary income | ¥1.3 billion | Parent only |
| Ending finished goods cos | ¥1.1 billion | Parent only |
| Beginning finished goods cos | ¥0.9 billion | Parent only |
| Net cash provided by (used in) financing activities | ¥-0.5 billion | Parent only |
| Selling, general and administrative expenses | ¥2.7 billion | Parent only |
| Provision of allowance for doubtful accounts | ¥0.04 million | Parent only |
| Miscellaneous income | ¥0.59 million | Parent only |
Statement of changes in equity (2 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Total changes during the period | ¥0.3 billion | Parent only |
| Net changes in items other than shareholders' equity | ¥-0.40 million | Parent only |
Statement of cash flows (28 items)
| Item | Value | Consolidated / Non-consolidated |
|---|---|---|
| Other | ¥20.66 million | Parent only |
| Repayments of lease obligations | ¥-6.75 million | Parent only |
| Increase decrease in notes and accounts payable trade | ¥-0.4 billion | Parent only |
| Interest expenses paid | ¥-12.85 million | Parent only |
| Interest and dividends income received | ¥1.76 million | Parent only |
| Interest and dividend income | ¥-1.86 million | Parent only |
| Loss on retirement of non-current assets | ¥28.70 million | Parent only |
| Decrease increase in notes and accounts receivable trade | ¥-99.21 million | Parent only |
| Subtotal | ¥1.0 billion | Parent only |
| Proceeds from collection of guarantee deposits | ¥4.36 million | Parent only |
| Payments for guarantee deposits | ¥-2.88 million | Parent only |
| Interest expenses | ¥12.34 million | Parent only |
| Gain on reversal of share acquisition rights | ¥-0.40 million | Parent only |
| Purchase of property plant and equipment | ¥-0.3 billion | Parent only |
| (Increase) decrease in accounts receivables other | ¥-10.32 million | Parent only |
| Decrease/increase in consumption taxes receivable/payable | ¥-47.71 million | Parent only |
| Increase/(decrease) in accounts payable - expenses | ¥6.67 million | Parent only |
| Increase (decrease) in accounts payable-other | ¥50.26 million | Parent only |
| Decrease (increase) in inventories | ¥-0.2 billion | Parent only |
| Income taxes paid | ¥-0.4 billion | Parent only |
| Depreciation | ¥0.3 billion | Parent only |
| Purchase of intangible assets | ¥-0.25 million | Parent only |
| Decrease/increase in short-term loans payable | ¥0.2 billion | Parent only |
| Increase (decrease) in allowance for doubtful accounts | ¥0.04 million | Parent only |
| Payments for asset retirement obligations | ¥-3.70 million | Parent only |
| Dividends | ¥-0.7 billion | Parent only |
| Proceeds from long term loans payable | ¥0.5 billion | Parent only |
| Repayment of long term loans payable | ¥-0.5 billion | Parent only |
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Net cash provided by (used in) operating activities | ¥0.6 billion | Parent only | Disclosed |
| Dividend per share | 20 | Parent only | Disclosed |
| Number of employees | 185 | Parent only | Disclosed |
| Net assets | ¥7.8 billion | Parent only | Disclosed |
| Net sales | ¥10.3 billion | Parent only | Disclosed |
| Operating income | ¥1.3 billion | Parent only | Disclosed |
| Ordinary income | ¥1.3 billion | Parent only | Disclosed |
| Total assets | ¥11.4 billion | Parent only | Disclosed |
| Operating margin | 12.4% | Parent only | Calculated |
| Net margin | Not disclosed | Not applicable | Not calculated (a required value is not disclosed) |
| Sales per employee | 55626941 yen | Parent only | Calculated |
| Total asset turnover | 0.91 times | Parent only | Calculated |
| Net assets to total assets | 68.4% | Parent only | Calculated |